Acetazolamide-induced myokymia

Parkinsonism Relat Disord. 2015 May;21(5):542-3. doi: 10.1016/j.parkreldis.2015.02.001. Epub 2015 Feb 14.

Authors

Nicholas A Howell¹, John Maher², Alfonso Fasano³

Affiliations

¹ Institute of Health Policy, Management, and Evaluation, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
² Royal Victoria Regional Health Centre, Barrie, Ontario, Canada.
³ Morton and Gloria Shulman Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, Ontario, Canada. Electronic address: [email protected].

PMID: 25715652
DOI: 10.1016/j.parkreldis.2015.02.001

No abstract available

Keywords: Acetazolamide; Idiopathic intracranial hypertension; Myokymia.

Publication types

Case Reports
Letter

MeSH terms

Acetazolamide / adverse effects*
Adult
Carbonic Anhydrase Inhibitors / adverse effects
Female
Humans
Myokymia / chemically induced*
Myokymia / diagnosis*

Substances

Carbonic Anhydrase Inhibitors
Acetazolamide